04.09.21
Brazilian Health Regulator Anvisa Authorizes Trials for GSK-Medicago COVID Vaccine
SAO PAULO (Reuters) – Brazilian health regulator Anvisa approved on Thursday the beginning of clinical trials in the country for a new COVID vaccine developed by Canada’s Medicago R&D Inc and GlaxoSmithKline PLC, Anvisa said in a statement. Anvisa said the companies were authorized to conduct phase 3 trials in the country. The companies are